相关实验视频
Updated: Jan 12, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.7K
患有CKD的人的体重管理经验:一种定性研究
Mateen Noori1, Rutvi Brahmbhatt1, Kristin K Clemens1,2,3,4
1Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Canadian journal of kidney health and disease
|November 3, 2025
概括
这项研究探讨了晚期慢性病 (CKD) 和肥胖症患者如何经历体重管理. 这些发现突出了医疗保健支持和患者自主性的未满足需求,指导了未来针对肥胖和CKD的以患者为中心的干预措施.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肥胖医学 肥胖医学
- 质量健康研究 质量健康研究
背景情况:
- 肥胖是慢性病 (CKD) 进展的重要危险因素.
- 对于晚期CKD (G4-5D阶段) 患者来说,脏移植是最佳的,但由于手术风险增加和移植存活率降低,肥胖症构成了障碍.
- 了解患者对体重管理的看法对于改善护理至关重要.
研究的目的:
- 探索晚期CKD (G4-5D) 和肥胖患者在体重管理方面的生活经验.
- 确定患者的信念,经验和与减肥策略相关的期望.
- 为开发以患者为中心的重量管理方法提供信息.
主要方法:
- 进行了一项描述性定性研究,其中12名参与者患有晚期CKD (G4-5ND) 和肥胖症.
- 用专题分析和现象学框架来分析采访数据.
- 诱导式,开放式编码被用来识别新出现的主题.
主要成果:
- 六个关键主题出现了:医疗保健支持的优势和差距,社会和系统影响,以前的减肥经验,健康状况的限制,体重管理的知识和动机,以及治疗决策中的个人自主权.
- 参与者表达了对体重管理的医疗保健支持的各种经验.
- 个人因素和健康状况显著影响了体重管理工作.
结论:
- 医疗保健提供者应主动识别和解决患者在体重管理方面的未满足需求.
- 研究结果强调了以患者为中心的对话和共享决策在治疗慢性病患者的肥胖方面的重要性.
- 未来的干预措施应考虑患有CKD和肥胖症的个体所面临的多方面的经验和挑战.
相关概念视频
01:18Chronic Kidney Disease IV: Nursing Management
309
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
309
01:28Chronic Kidney Disease III: Interprofessional Care
332
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
332
01:24Chronic Kidney Disease II: Clinical Manifestations
540
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
540
01:25Chronic Kidney Disease I: Introduction
553
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
553
01:22Acute Kidney Injury VI: Nursing Management
376
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
376
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
182
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
182